Prioritizing Harm Reduction Funding Without Stigma
The intersection of the Covid-19 pandemic and opioid epidemic has necessitated federal funding toward harm reduction.
produced by: Boston University School of Public Health
C To, BA, is a current research assistant at the Harvard TH Chan School of Public Health and will receive their MSPH in Health Policy student at the Johns Hopkins Bloomberg School of Public Health in May 2022. Their research interests include public policy, harm reduction, drug decriminalization, and the social determinants of health.
The intersection of the Covid-19 pandemic and opioid epidemic has necessitated federal funding toward harm reduction.